Voskhod venture fund, created at the end of 2021, aims to develop high-tech companies to tackle problems in industrial development in the Far East region. The Fund invests in Russian deeptech projects at the commercialization and scaling stages, and supports early-stage projects. The main areas of investment are biotechnologies and medicine, robotics, new mobility, green technologies, agricultural technologies and food tech, micro- and optoelectronics.
Interros will invest 10 billion rubles in the fund's projects over the course of five years.
By the end of 2022, the fund has invested in six projects. In particular, 150 million rubles were invested in the development of the Sciberia neural network created in Yakutia, a medical image analysis system based on computer vision and artificial intelligence technologies. Sciberia currently has two diagnostic programs in its final stages for analyzing CT scans. The first, Sciberia Lungs, will be used as the lead system for diagnosing COVID-19 and lung cancer. The next program, Sciberia Head, detects signs of ischemic and hemorrhagic strokes.